Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Milestone Pharmaceuticals Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +4 vs. Q2 2024
- Shares held
- 28.7M
- +3.47M (+13.8%) vs. Q2 2024
- Total value
- $43.6M
- +$10.3M (+30.8%) vs. Q2 2024
- New holders
- 5
- 9 more added
- Sold out
- 1
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,971,344 | $7.56M | 0.00% | +4,971,344 | New |
| RTW Investments, LP | 3,256,102 | $4.95M | 0.07% | 00.0% | Unchanged |
| Millennium Management LLC | 2,778,525 | $4.22M | 0.00% | +28,595+1.0% | Added |
| Alta Fundamental Advisers LLC | 2,658,589 | $4.04M | 1.67% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,061,522 | $3.13M | 0.00% | −85,822−4.0% | Reduced |
| OrbiMed Advisors LLC | 2,000,000 | $3.04M | 0.06% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,750,000 | $2.66M | 0.22% | 00.0% | Unchanged |
| Lion Point Capital, LP | 1,654,154 | $2.51M | 10.09% | −686,053−29.3% | Reduced |
| Goldman Sachs Group Inc | 1,353,067 | $2.06M | 0.00% | 00.0% | Unchanged |
| Bleichroeder LP | 1,326,085 | $2.02M | 0.54% | 00.0% | Unchanged |
| BML Capital Management, LLC | 1,136,091 | $1.73M | 1.02% | +33,196+3.0% | Added |
| Stonepine Capital Management, LLC | 999,790 | $1.52M | 0.96% | −239,409−19.3% | Reduced |
| Morgan Stanley | 918,312 | $1.40M | 0.00% | +89,658+10.8% | Added |
| Ikarian Capital, LLC | 466,019 | $708.3K | 0.22% | 00.0% | Unchanged |
| Altium Capital Management LP | 440,000 | $668.8K | 0.20% | −572,368−56.5% | Reduced |
| Boxer Capital, LLC | 309,007 | $469.7K | 0.02% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 70,590 | $107.3K | 0.00% | +11,067+18.6% | Added |
| Ancora Advisors, LLC | 60,000 | $91.2K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 54,245 | $82.5K | 0.00% | −439−0.8% | Reduced |
| Atria Investments LLC | 40,421 | $61.4K | 0.00% | +12,430+44.4% | Added |
| Dimensional Fund Advisors LP | 39,450 | $60.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 30,779 | $46.8K | 0.00% | 00.0% | Unchanged |
| PVG Asset Management Corp | 30,345 | $46.1K | 0.19% | +30,345 | New |
| BNP Paribas Arbitrage, SA | 29,209 | $44.4K | 0.00% | +4,609+18.7% | Added |
| ADAR1 Capital Management, LLC | 27,931 | $42.5K | 0.01% | −174,529−86.2% | Reduced |
| Northern Trust Corp | 27,336 | $41.5K | 0.00% | −448−1.6% | Reduced |
| Cetera Investment Advisers | 24,671 | $37.5K | 0.00% | +3,982+19.2% | Added |
| Two Sigma Securities, LLC | 23,133 | $35.2K | 0.00% | +23,133 | New |
| Valeo Financial Advisors, LLC | 20,000 | $30.4K | 0.00% | +10,000+100.0% | Added |
| Clear Creek Financial Management, LLC | 19,500 | $29.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,311 | $29.4K | 0.00% | +388+2.1% | Added |
| Geode Capital Management, LLC | 17,576 | $26.7K | 0.00% | 00.0% | Unchanged |
| Beta Wealth Group, Inc. | 14,127 | $21.5K | 0.01% | 00.0% | Unchanged |
| Creative Planning | 13,080 | $19.9K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 11,074 | $16.8K | 0.00% | +11,074 | New |
| Federation des caisses Desjardins du Quebec | 10,500 | $16.0K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 7,100 | $10.8K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,500 | $9.88K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1,000 | $1.53K | 0.00% | −70−6.5% | Reduced |
| Royal Bank of Canada | 800 | $1.00K | 0.00% | +800 | New |
| Barclays PLC | 100 | $152 | 0.00% | 00.0% | Unchanged |
| Oliver Lagore Vanvalin Investment Group | 100 | $152 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 214 | $0 | 0.00% | −977−82.0% | Reduced |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −194−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |